These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33624931)

  • 1. Citric acid functionalized nitinol stent surface promotes endothelial cell healing.
    Ceresnakova M; Murray D; McGourty KD; Butler J; Neilan J; Soulimane T; Hudson SP
    J Biomed Mater Res A; 2021 Sep; 109(9):1549-1559. PubMed ID: 33624931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidates for smart cardiovascular medical device coatings: A comparative study with endothelial and smooth muscle cells.
    Ceresnakova M; Murray D; Soulimane T; Hudson SP
    Eur J Pharmacol; 2021 Nov; 910():174490. PubMed ID: 34492283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ endothelialization of intravascular stents coated with an anti-CD34 antibody functionalized heparin-collagen multilayer.
    Lin Q; Ding X; Qiu F; Song X; Fu G; Ji J
    Biomaterials; 2010 May; 31(14):4017-25. PubMed ID: 20149438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pro-Healing Nanomatrix-Coated Stent Analysis in an
    Zhang X; Chen J; Brott BC; Anderson PG; Hwang PTJ; Sherwood J; Huskin G; Yoon YS; Virmani R; Jun HW
    ACS Appl Mater Interfaces; 2022 Nov; 14(46):51728-51743. PubMed ID: 36346768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
    Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
    J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting In-Stent-Stenosis with RGD- and CXCL1-Coated Mini-Stents in Mice.
    Simsekyilmaz S; Liehn EA; Weinandy S; Schreiber F; Megens RT; Theelen W; Smeets R; Jockenhövel S; Gries T; Möller M; Klee D; Weber C; Zernecke A
    PLoS One; 2016; 11(5):e0155829. PubMed ID: 27192172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of electrospun PLLA/PEGDMA polymer coatings for vascular stent material.
    Boodagh P; Guo DJ; Nagiah N; Tan W
    J Biomater Sci Polym Ed; 2016 Aug; 27(11):1086-99. PubMed ID: 27137629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymer-free immobilization of a cyclic RGD peptide on a nitinol stent promotes integrin-dependent endothelial coverage of strut surfaces.
    Joner M; Cheng Q; Schönhofer-Merl S; Lopez M; Neubauer S; Mas-Moruno C; Laufer B; Kolodgie FD; Kessler H; Virmani R
    J Biomed Mater Res B Appl Biomater; 2012 Apr; 100(3):637-45. PubMed ID: 22278946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings.
    Hu T; Lin S; Du R; Fu M; Rao Q; Yin T; Huang Y; Wang G
    Biomater Sci; 2017 Aug; 5(9):1845-1857. PubMed ID: 28676873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells.
    Liu HT; Li F; Wang WY; Li XJ; Liu YM; Wang RA; Guo WY; Wang HC
    Tex Heart Inst J; 2010; 37(2):194-201. PubMed ID: 20401293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pro-endothelialization of nitinol alloy cardiovascular stents enhanced by the programmed assembly of exosomes and endothelial affinity peptide.
    Li L; Yu Y; Sun X; Wang X; Yang X; Yu Q; Kang K; Wu Y; Yi Q
    J Mater Chem B; 2024 May; 12(17):4184-4196. PubMed ID: 38592788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An electrospun fiber-covered stent with programmable dual drug release for endothelialization acceleration and lumen stenosis prevention.
    Zhang Y; Wang J; Xiao J; Fang T; Hu N; Li M; Deng L; Cheng Y; Zhu Y; Cui W
    Acta Biomater; 2019 Aug; 94():295-305. PubMed ID: 31195144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed re-endothelialization with rapamycin-coated stents is rescued by the addition of a glycogen synthase kinase-3beta inhibitor.
    Ma X; Hibbert B; Dhaliwal B; Seibert T; Chen YX; Zhao X; O'Brien ER
    Cardiovasc Res; 2010 May; 86(2):338-45. PubMed ID: 20167573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between catheter-based delivery of paclitaxel after bare-metal stenting and drug-eluting stents in coronary artery disease patients at high risk for in-stent restenosis.
    El-Mokadem M; El-Ramly M; Hassan A; Boshra H; AbdelWahab A
    Cardiovasc Revasc Med; 2017 Dec; 18(8):596-600. PubMed ID: 28625402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices.
    Dake MD; Ansel GM; Bosiers M; Holden A; Iida O; Jaff MR; Lottes AE; O'Leary EE; Saunders AT; Schermerhorn M; Yokoi H; Zeller T
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):8-19. PubMed ID: 31502026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arsenic Trioxide-Coated Stent Is an Endothelium-Friendly Drug Eluting Stent.
    Zhao Y; Du R; Zhou T; Yang D; Huang Y; Wang Y; Huang J; Ma X; He F; Qiu J; Wang G
    Adv Healthc Mater; 2018 Aug; 7(15):e1800207. PubMed ID: 29770610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study.
    Dake MD; Scheinert D; Tepe G; Tessarek J; Fanelli F; Bosiers M; Ruhlmann C; Kavteladze Z; Lottes AE; Ragheb AO; Zeller T;
    J Endovasc Ther; 2011 Oct; 18(5):613-23. PubMed ID: 21992630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.